ImmuCell
ICCC
30 hedge funds and large institutions have $5.42M invested in ImmuCell in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 0 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
15% more funds holding
Funds holding: 26 → 30 (+4)
8% more capital invested
Capital invested by funds: $5.03M → $5.42M (+$397K)
0.97% more ownership
Funds ownership: 12.67% → 13.64% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$110K |
| 2 |
PP
Prosperity Planning
Kansas City,
Missouri
|
+$104K |
| 3 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$26.5K |
| 4 |
EFS
Essex Financial Services
Essex,
Connecticut
|
+$17.5K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$35.7K |
| 2 |
OMC
Overbrook Management Corp
New York
|
-$17.4K |
| 3 |
Renaissance Technologies
New York
|
-$17.3K |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$2.11K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$188 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
US Bancorp
Minneapolis,
Minnesota
| $3.07K | – | – | – |
|
|
GWM
27
Geneos Wealth Management
Englewood,
Colorado
| $1.25K | – | – | – |
|
28
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $777 | – | – | – |
|
29
Wells Fargo
San Francisco,
California
| $196 | +$6 | +1 | +3% |
|
30
Fidelity Investments
Boston,
Massachusetts
| $5 | +$6 | +1 | New |
|
ICCC Hedge Fund Activity: Q1 2023 in Review
30 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2023, worth a combined $5.42M — up 7.9% from $5.03M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ICCC positions and 0 closed out — a net gain of 4 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was Morgan Stanley, cutting an estimated $35.7K.
- 30 institutional investors held ImmuCell (ICCC) as of Q1 2023, up from 26 in Q4 2022.
- Funds reported $5.42M of ImmuCell stock for Q1 2023, up 7.9% quarter-over-quarter.
- 4 funds opened new ImmuCell positions in Q1 2023 and 0 closed out, a net change of +4 holders.
- The largest ImmuCell buyer in Q1 2023 was Citadel Advisors, an estimated $110K added.
- The largest ImmuCell seller in Q1 2023 was Morgan Stanley, an estimated $35.7K sold.
Based on aggregated 13F filings for Q1 2023.